Velarion Records
Free. Unsubscribe any time.

Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics, Inc. filed 67 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 11 reporting owners, covering 106 transactions and 1,249,906 shares. None carries the SEC's AFF10B5ONE flag; all 67 name a plan in a footnote. 9 results prints are on file in the same window.

What stands out

Trades in Travere Therapeutics, Inc. 106

Adoption dates in Travere Therapeutics, Inc. 0

Results prints in Travere Therapeutics, Inc. 9

Trades before a print in Travere Therapeutics, Inc. 9

Interval to Travere Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.